IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients

BACKGROUND: Advances in pathophysiology and treatment of ankylosing spondylitis (AS) was recently demonstrated. However, the effect of anti-TNF in the newly described inflammatory pathways involved pathogenesis of this disease remains to be determined. The aim of our study was, therefore, to investi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Arthritis Res Ther
Auteurs principaux: Milanez, Fernanda Manente, Saad, Carla G. S., Viana, Vilma T., Moraes, Júlio C. B., Périco, Grégory Vinícius, Sampaio-Barros, Percival Degrava, Goncalves, Célio R., Bonfá, Eloísa
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4765065/
https://ncbi.nlm.nih.gov/pubmed/26912133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-0949-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires